Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne is poised for growth with a solid financial performance, strategic expansion into the MRD market, and a focus on operational efficiency and future growth initiatives. Their positive earnings, new in-network contracts, and recent product launches demonstrate a strong potential for increased revenue and market share. Additionally, their conservative fiscal culture and lower accumulated deficit position them well for sustainable growth compared to their competitors.

Bears say

BillionToOne is a commercial-stage company with a portfolio of ultrasensitive liquid biopsy tests in the prenatal and oncology markets. However, despite promising technology and early revenue growth, there are concerns about the company's ability to penetrate the large and highly competitive market, as well as potential reimbursement challenges. Additionally, with a relatively small team of 620 employees, there may be limitations on the company's scalability.

Billiontoone Inc (BLLN) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 7 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $126.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $126.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.